Stockholm - Delayed Quote SEK

S2Medical AB (publ) (S2M.ST)

0.0114
+0.0005
+(4.59%)
At close: 5:29:56 PM GMT+2
Loading Chart for S2M.ST
  • Previous Close 0.0109
  • Open 0.0112
  • Bid 0.0111 x --
  • Ask 0.0115 x --
  • Day's Range 0.0105 - 0.0117
  • 52 Week Range 0.0055 - 0.0737
  • Volume 7,089,748
  • Avg. Volume 8,171,611
  • Market Cap (intraday) 9.625M
  • Beta (5Y Monthly) 2.01
  • PE Ratio (TTM) 1.14
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover. The company also distributes Silverlon dressings that deliver a flow of silver ions into the wound; and BIOPAD, an ivory-white soft sponge, and BIOSPRAY, a medication powder form with spray. In addition, it operates the wound healing center under the S2Clinic name. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

www.s2m.se

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: S2M.ST

View More

Performance Overview: S2M.ST

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

S2M.ST
8.57%
OMX Stockholm 30 Index (^OMX)
1.37%

1-Year Return

S2M.ST
75.74%
OMX Stockholm 30 Index (^OMX)
5.40%

3-Year Return

S2M.ST
98.57%
OMX Stockholm 30 Index (^OMX)
24.83%

5-Year Return

S2M.ST
99.41%
OMX Stockholm 30 Index (^OMX)
56.68%

Compare To: S2M.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: S2M.ST

View More

Valuation Measures

As of 5/7/2025
  • Market Cap

    9.20M

  • Enterprise Value

    8.20M

  • Trailing P/E

    1.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.62

  • Price/Book (mrq)

    0.78

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    1.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    38.72%

  • Return on Assets (ttm)

    18.33%

  • Return on Equity (ttm)

    85.75%

  • Revenue (ttm)

    14.91M

  • Net Income Avi to Common (ttm)

    5.77M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -7.02M

Research Analysis: S2M.ST

View More

People Also Watch